A team of the Institute of Neurosciences of the University of Barcelona has participated in the design of the first light-activated drug — the JF-NP-26, for the treatment of pain, according to a research with animal models published in the journal eLife. The new study is conducted by the teams led by Professor Francisco Ciruela, from…
New Target for Disease Therapies Caused by Lack of Oxygen
An international scientific team has developed a new small molecule –VH298- which can provoke a hypoxic response controlled from outside the cells, according to a study recently published in the magazine Nature Communications with its first authors being the expert Carles Galdeano, Beatriu de Pinós researcher at the Department of Pharmacy and Pharmaceutical Technology and…